GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Medtronic, Inc. (MDT) [hlAlert]

Rating:
Hold MDT

Medtronic, Inc. (MDT) rated Hold

Posted on: Tuesday,  Oct 16, 2007  9:39 PM ET by BMO Capital Markets

Medtronic (MDT) rated Market
Perform with price target $55 by BMO Capital Markets.

Medtronic, Inc. (Medtronic) is a global player in medical technology. The Company operates in seven segments that manufacture and sell device-based medical therapies: Cardiac Rhythm Disease Management, Spinal, CardioVascular, Neuromodulation, Diabetes, Surgical Technologies and Physio-Control. Through these seven segments, the Company develops, manufactures and markets its medical devices in more than 120 countries. Its primary products include those for cardiac rhythm disorders, cardiovascular disease, neurological disorders, spinal conditions and musculoskeletal trauma, urological and digestive disorders, diabetes, and ear, nose and throat conditions. The primary markets for products are the United States, Western Europe and Japan. In July 2008, it acquired Restore Medical, Inc. In November 2008, Medtronic acquired CryoCath Technologies Inc. In February 2009, it acquired Ablation Frontiers, Inc. and Ventor Technologies Ltd. In April 2009, Medtronic acquired CoreValve, Inc.

The U.S. Equity Research team comprises over 25 analysts located in New York, Atlanta, Boston, Denver, Houston and Los Angeles. We cover more than 375 stocks and also provide equity strategy, quantitative analysis and portfolio management services to our clients. Our goal is to identify the best sectors to invest in, and the best stocks within those sectors, in order to help our clients maximize their portfolio returns. Our award-winning analysts provide research that is informative, perceptive and actionable.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/16/2007 9:39 PM Hold
None
50.37 55.00
as of 12/24/2008
1 Week down  -8.42 %
1 Month up  0.57 %
3 Months down  -8.50 %
1 YTD down  -38.36 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy